56:
116:
76:
32:
302:
137:
367:
362:
96:
150:
213:
230:
356:
343:
290:
331:
319:
278:
242:
208:
120:
100:
80:
36:
196:
184:
179:
167:
60:
218:
314:
162:
254:
20:
This category has the following 5 subcategories, out of 5 total.
136:
The following 20 pages are in this category, out of 20 total.
266:
133:
Pages in category "Experimental anti-obesity drugs"
8:
138:This list may not reflect recent changes
7:
142:
53:
22:
14:
57:Cannabinoid receptor antagonists
303:Prohibitin-targeting peptide 1
1:
384:
117:Neuropeptide Y antagonists
77:Glucagon receptor agonists
33:Amylin receptor agonists
151:5-HT2C receptor agonist
368:Experimental drugs
363:Anti-obesity drugs
214:Denatonium acetate
97:METAP2 inhibitors
375:
231:Etiocholanedione
122:
102:
82:
62:
55:
38:
383:
382:
378:
377:
376:
374:
373:
372:
353:
352:
351:
350:
349:
348:
336:
324:
307:
295:
283:
271:
259:
247:
235:
223:
201:
189:
172:
155:
130:
129:
128:
127:
124:
123:
107:
104:
103:
87:
84:
83:
67:
64:
63:
52:
43:
40:
39:
12:
11:
5:
381:
379:
371:
370:
365:
355:
354:
347:
346:
340:
337:
335:
334:
328:
325:
323:
322:
317:
311:
308:
306:
305:
299:
296:
294:
293:
287:
284:
282:
281:
275:
272:
270:
269:
263:
260:
258:
257:
251:
248:
246:
245:
239:
236:
234:
233:
227:
224:
222:
221:
216:
211:
205:
202:
200:
199:
193:
190:
188:
187:
182:
176:
173:
171:
170:
165:
159:
156:
154:
153:
147:
144:
143:
134:
131:
126:
125:
115:
114:
111:
108:
106:
105:
95:
94:
91:
88:
86:
85:
75:
74:
71:
68:
66:
65:
51:
50:
47:
44:
42:
41:
31:
30:
27:
24:
23:
18:
15:
13:
10:
9:
6:
4:
3:
2:
380:
369:
366:
364:
361:
360:
358:
345:
344:Vutiglabridin
342:
341:
338:
333:
330:
329:
326:
321:
318:
316:
313:
312:
309:
304:
301:
300:
297:
292:
289:
288:
285:
280:
277:
276:
273:
268:
265:
264:
261:
256:
253:
252:
249:
244:
241:
240:
237:
232:
229:
228:
225:
220:
217:
215:
212:
210:
207:
206:
203:
198:
195:
194:
191:
186:
183:
181:
178:
177:
174:
169:
166:
164:
161:
160:
157:
152:
149:
148:
145:
141:
139:
132:
118:
113:
112:
109:
98:
93:
92:
89:
78:
73:
72:
69:
58:
54:
49:
48:
45:
34:
29:
28:
25:
21:
17:Subcategories
16:
291:Orforglipron
135:
19:
332:Tesofensine
320:Survodutide
279:Monlunabant
243:Fluasterone
209:Dapiglutide
357:Categories
197:Cetilistat
185:Bimagrumab
180:Benfluorex
168:Azalanstat
61:(1 C, 1 P)
219:Diazoxide
315:S-309309
163:AdipoRon
255:GLY-200
121:(5 P)
101:(3 P)
81:(9 P)
37:(8 P)
267:HU6
146:0–9
359::
140:.
119:
99:
79:
59:
35:
339:V
327:T
310:S
298:P
286:O
274:M
262:H
250:G
238:F
226:E
204:D
192:C
175:B
158:A
110:N
90:M
70:G
46:C
26:A
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.